Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$35.4M |
| 2 |
CDW
CDW
|
+$16.8M |
| 3 |
Bausch Health
BHC
|
+$187K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$263M |
| 2 |
Morgan Stanley
MS
|
+$185M |
| 3 |
A.O. Smith
AOS
|
+$110M |
| 4 |
Seagate
STX
|
+$79.1M |
| 5 |
AFI
Armstrong Flooring, Inc.
AFI
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 48.42% |
| 2 | Technology | 22.73% |
| 3 | Consumer Discretionary | 8.81% |
| 4 | Industrials | 8.27% |
| 5 | Real Estate | 7.44% |
Similar funds
Mason Morfit's Q4 2020 Portfolio in Review
As of Q4 2020, Mason Morfit held 13 positions worth $8.62B, up 21% from $7.11B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mason Morfit withdrew a net $589M in Q4 2020, closing 2 positions and reducing 3 holdings. Its most notable exit was A.O. Smith, an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Financials at 48% of assets, down from 50% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Mason Morfit opened a new position in Fiserv Inc worth $37.4M.
- Mason Morfit's largest Q4 2020 buy was Fiserv Inc: 328,281 shares worth $37.4M.
- Mason Morfit added most to CDW in Q4 2020, an estimated $16.8M increase.
- Mason Morfit's biggest Q4 2020 reduction was KKR & Co, cutting an estimated $263M.
- Mason Morfit fully exited A.O. Smith in Q4 2020, selling an estimated $110M.
- Mason Morfit's ten largest holdings make up 100% of its $8.62B portfolio in Q4 2020.
- Mason Morfit opened 1 new position and closed 2 in Q4 2020.
- Mason Morfit's portfolio value rose 21% quarter-over-quarter to $8.62B.
Based on ValueAct Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.